Indegene Limited — Capital/Financing Update 2024

Nov 18, 2024

INDGN/SE/2024-25/70

==> picture [78 x 76] intentionally omitted <==

November 18, 2024

BSE Limited, National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai- 400001, India. Mumbai – 400 051, India. Scrip Code: 544172 Trading symbol: INDGN

Dear Sir / Madam,

Sub: Indegene Expands Global Delivery Network, Announces A New Center in Hyderabad:

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is a press release dated November 18, 2024, titled ‘Indegene Expands Global Delivery Network, Announces A New Center In Hyderabad’.

The above information will be made available on the website of the Company: https://www.indegene.com/

A copy of the Press Release is enclosed for your reference.

This is for your information and records.

For Indegene Limited

(Formerly known as Indegene Private Limited)

Srishti Digitally signed by Srishti Ramesh Ramesh Kaushik Date: 2024.11.18 Kaushik 13:14:29 +05'30'

Srishti Ramesh Kaushik Company Secretary and Compliance officer

==> picture [141 x 29] intentionally omitted <==

Indegene Limited (Formerly Indegene Private Limited), Third Floor, Aspen G-4 Block, Manyata Embassy Business Park (SEZ), Outer Ring Road, Nagawara, Bengaluru- 560 045, Karnataka, India

Phone: +91 80 4674 4567, +91 80 4644 7777 www.indegene.com

CIN: U73100KA1998PLC102040

==> picture [64 x 64] intentionally omitted <==

Press release

Indegene Expands Global Delivery Network, Announces A New Center In Hyderabad

Bengaluru, India, November 18, 2024: Indegene, a digital-first life sciences commercialization company, announced a new center in Hyderabad to strengthen its global delivery operations and better address growing business needs.

As the pharma industry faces increasing pressure to innovate and adapt, this new center will play a key role in helping companies accelerate their transformation. This move aligns with Indegene’s purpose: to enable healthcare organizations to be future-ready by combining deep medical expertise with fit-forpurpose technology.

India is rapidly emerging as a critical hub for global pharma companies, fueled by its vast pool of skilled medical and technology talent. These companies are increasingly seeking a partner with core domain expertise and life sciences-contextualized technology to help them scale their operations in a non-linear, technology-led way.

“Indegene has a strong track record in helping global pharma companies reimagine their commercialization processes, drive innovation with GenAI, and fully integrate these capabilities into their business processes,” said Manish Gupta, Chairman and CEO of Indegene. “With the new center, we are further strengthening our capabilities to help life sciences companies modernize and transform their commercial, medical and clinical operations, with our fit-for-purpose technology.”

For more information on Indegene's global delivery capabilities, please visit: https://www.indegene.com/how-we-deliver/tech-led-gcc-capabilities

Indegene’s leadership in life sciences commercialization has been further recognized by the Everest Group, which named the company a Leader in its Life Sciences Digital Services Specialist PEAK Matrix[® ] Assessment 2024. Additionally, HFS Research recently recognized Indegene as a Leader in GenAI in Life Sciences, further validating the latter’s ongoing commitment to innovation and excellence in the industry.

With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. This vast global footprint underscores Indegene’s ability to scale and meet the evolving needs of the world’s leading pharma organizations across markets.

About Indegene

Indegene Limited (BSE: 544172, NSE: INDGN) is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives Indegene’s team and their purpose to enable healthcare organizations to be future-ready. To learn more, please visit www.indegene.com

For media inquiries, please contact: Yadunandan K V | yadunandan.kv@indegene.com